Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Playtika Holding Corp.Playtika Reports 8.4% Revenue Growth to $706M in Q1 2025, Net Income Declines
SCANSOURCE, INC.ScanSource Reports Decline in Revenue and Profitability for Quarter Ending March 31, 2025
PATRICK INDUSTRIES INCPatrick Industries Reports 7% Revenue Growth to $1.003 Billion in Q1 2025
Rallybio CorpRallybio Reports $212,000 Revenue in Q1 2025, Net Loss Improves to $9.4 Million
Clear Secure, Inc.Clear Secure Reports 18% Revenue Growth to $211.4 Million in Q1 2025
ACORN ENERGY, INC.Acorn Energy Reports 45.3% Revenue Growth to $3.1 Million in Q1 2025
International Seaways, Inc.International Seaways Reports 65.7% Decline in Net Income for Q1 2025
MANNKIND CORPMannKind Corporation Reports 18% Revenue Growth to $78.4 Million in Q1 2025
Protara Therapeutics, Inc.Protara Therapeutics Reports $11.9 Million Net Loss in Q1 2025, Increases Investment in Clinical Programs
Artiva Biotherapeutics, Inc.Artiva Biotherapeutics Reports $20.3 Million Net Loss in Q1 2025
Arcadia Biosciences, Inc.Arcadia Biosciences Reports Net Income Turnaround and Revenue Growth in Q1 2025
Prime Medicine, Inc.Prime Medicine Reports $1.454 Million Revenue in Q1 2025, Net Loss Widens to $51.9 Million
RAPT Therapeutics, Inc.RAPT Therapeutics Reports $17.2 Million Net Loss, Improves Operating Expenses in Q1 2025
VERACYTE, INC.Veracyte Reports 18% Revenue Growth to $114.5 Million in Q1 2025
BlackRock TCP Capital Corp.BlackRock TCP Capital Corp. Reports Q1 2025 Financial Results with $32.2M Net Investment Income
TREDEGAR CORPTredegar Corporation Reports $10.1 Million Net Income in Q1 2025, Revenue Growth Driven by Aluminum Extrusions
PepGen Inc.PepGen Inc. Reports $30.2 Million Net Loss in Q1 2025, Increases R&D Spending
NCR VOYIX CorpNCR Voyix Reports $617 Million Revenue in Q1 2025, 13% Decrease Year-Over-Year
ImageneBio, Inc.Ikena Oncology Reports $8.6 Million Net Loss in Q1 2025, Plans Merger with Inmagene Biopharmaceuticals
Compass Therapeutics, Inc.Compass Therapeutics Reports $16.6 Million Net Loss in Q1 2025, Highlights Clinical Progress
NewAmsterdam Pharma Co N.V.NewAmsterdam Pharma Reports 113% Revenue Growth to $2.98 Million in Q1 2025
Third Harmonic Bio, Inc.Third Harmonic Bio Reports $15.8 Million Net Loss, Announces Plan of Dissolution
NOVAVAX INCNovavax Reports $666.7 Million Revenue and $518.6 Million Net Income in Latest Quarter
SOLAREDGE TECHNOLOGIES, INC.SolarEdge Technologies Reports Q1 2025 Financial Results with Revenue Growth and Reduced Losses
Wave Life Sciences Ltd.Wave Life Sciences Reports $46.9 Million Net Loss in Q1 2025, Revenue Declines to $9.2 Million